BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27369645)

  • 1. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.
    Sakellariou GT; Iliopoulos A; Konsta M; Kenanidis E; Potoupnis M; Tsiridis E; Gavana E; Sayegh FE
    Joint Bone Spine; 2017 May; 84(3):309-315. PubMed ID: 27369645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.
    Sakellariou GT; Anastasilakis AD; Bisbinas I; Oikonomou D; Gerou S; Polyzos SA; Sayegh FE
    Rheumatology (Oxford); 2015 May; 54(5):908-14. PubMed ID: 25349442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
    Sun W; Tian L; Jiang L; Zhang S; Zhou M; Zhu J; Xue J
    Clin Rheumatol; 2019 Apr; 38(4):989-995. PubMed ID: 30443790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
    Xie J; Yu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
    Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
    Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
    Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
    Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
    Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
    Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
    Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
    Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
    Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
    Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
    BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis.
    Sakellariou GT; Anastasilakis AD; Kenanidis E; Potoupnis M; Tsiridis E; Savvidis M; Kartalis N; Sayegh FE
    Rheumatol Int; 2015 Dec; 35(12):2109-14. PubMed ID: 26474866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis.
    Yucong Z; Lu L; Shengfa L; Yongliang Y; Ruguo S; Yikai L
    Clin Lab; 2014; 60(9):1527-31. PubMed ID: 25291949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis.
    Liao HT; Lin YF; Tsai CY; Chou TC
    Scand J Rheumatol; 2018 Jan; 47(1):56-61. PubMed ID: 28303752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1 in ankylosing spondylitis: Review and meta-analysis.
    Wu M; Chen M; Ma Y; Yang J; Han R; Yuan Y; Hu X; Wang M; Zhang X; Xu S; Liu R; Jiang G; Xu J; Shuai Z; Zou Y; Pan G; Pan F
    Clin Chim Acta; 2018 Jun; 481():177-183. PubMed ID: 29544750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
    Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis.
    Iaremenko O; Shynkaruk I; Fedkov D; Iaremenko K; Petelytska L
    Rheumatol Int; 2020 Dec; 40(12):2057-2063. PubMed ID: 32979065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
    Tošovský M; Bradna P; Andrýs C; Andrýsová K; Cermáková E; Soukup T
    Acta Medica (Hradec Kralove); 2014; 57(2):56-61. PubMed ID: 25257151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
    Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; De Socio A; Scriffignano S; Alessandri C; Lubrano E
    J Immunol Res; 2018; 2018():9101964. PubMed ID: 29854850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.
    Hu Z; Xu M; Li Q; Lin Z; Liao Z; Cao S; Wei Q; Zhang YL; Li T; Jin O; Huang J; Pan Y; Wu Y; Deng X; Gu J
    Int J Rheum Dis; 2012 Aug; 15(4):358-65. PubMed ID: 22898215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.
    Heiland GR; Appel H; Poddubnyy D; Zwerina J; Hueber A; Haibel H; Baraliakos X; Listing J; Rudwaleit M; Schett G; Sieper J
    Ann Rheum Dis; 2012 Apr; 71(4):572-4. PubMed ID: 22186710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.